A Randomized Double-Blind Evaluation of the Pharmacokinetics Safety and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection
J
Jean Molleston, MD
Primary Investigator
Overview
The purpose of this study is to evaluate the safety, tolerability, and effectiveness of TAF against the Hepatitis B Virus in all of the enrolled adolescent subjects.
Description
The purpose of this study is to evaluate the safety, tolerability, and effectiveness of TAF against the Hepatitis B Virus in all of the enrolled adolescent subjects.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Chronic Hepatitis B Virus Infection
-
Age: - 100 Years
-
Gender: All
Updated on
29 Apr 2024.
Study ID: 1611090671
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
